Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

Two series of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives exhibiting diverse functionality at rat MT(1) and MT(2) receptors are reported. Compounds 11f and 18b (MT(1)/MT(2) agonist) have human microsomal intrinsic clearance comparable to ramelteon.

Knowledge Graph

Similar Paper

Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands
Bioorganic & Medicinal Chemistry Letters 2011.0
Heterocyclic aminopyrrolidine derivatives as melatoninergic agents
Bioorganic & Medicinal Chemistry Letters 2003.0
Indanyl piperazines as melatonergic MT2 selective agents
Bioorganic & Medicinal Chemistry Letters 2003.0
N-(Substituted-anilinoethyl)amides: Design, Synthesis, and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands
Journal of Medicinal Chemistry 2007.0
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands
Bioorganic & Medicinal Chemistry 2009.0
N-{2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl}acetamide: an orally bioavailable melatonin receptor agonist
Bioorganic & Medicinal Chemistry Letters 2004.0
Synthesis of new N-(arylcyclopropyl)acetamides and N-(arylvinyl)acetamides as conformationally-restricted ligands for melatonin receptors
Bioorganic & Medicinal Chemistry Letters 2013.0
Design and Synthesis ofN-(3,3-Diphenylpropenyl)alkanamides as a Novel Class of High-Affinity MT<sub>2</sub>-Selective Melatonin Receptor Ligands
Journal of Medicinal Chemistry 2006.0
Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands
European Journal of Medicinal Chemistry 2011.0
Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist
Journal of Medicinal Chemistry 2021.0